Molgo J, Marchot P, Araoz R, Benoit E, Iorga BI, Zakarian A, Taylor P, Bourne Y, Servent D (2017)
Cyclic imine toxins from dinoflagellates: a growing family of potent antagonists of the nicotinic acetylcholine receptors
Journal of Neurochemistry 142 Suppl 2: 41
Benoit E, Barbier J, Popoff MR, Faure G, Molgo J, Servent D (2016)
Special Issue on Toxins: New targets and new functions
Toxicon 116: 1
Sigoillot SM, Bourgeois F, Karmouch J, Molgo J, Dobbertin A, Chevalier C, Houlgatte R, Leger J, Legay C (2016)
Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency
FASEB Journal 30: 2382
Araoz R, Bouet m, Bartolini M, Coquelle N, Colletier JP, Servent D, Molgo J, Jean L, Renard PY (2015)
Poster: Multi-target directed ligands: Electrophysiological characterization of an anticholinesterase inhibitor coupled to an agonist of alpha7 nicotinic acetylcholine receptor
Biochemical Pharmacology 97: 621
Araoz R, Hess P, Pelissier F, Benoit E, Servent D, Zakarian A, Molgo J (2015)
Poster: Cyclic imine toxins: From shellfish poisoning to neuroscience: The case of acyl derivatives
Biochemical Pharmacology 97: 622
Bourne Y, Sulzenbacher G, Radic Z, Araoz R, Reynaud M, Benoit E, Zakarian A, Servent D, Molgo J, Taylor P, Marchot P (2015)
Marine Macrocyclic Imines, Pinnatoxins A and G: Structural Determinants and Functional Properties to Distinguish Neuronal alpha7 from Muscle alpha1(2)betagammadelta nAChRs
Structure 23: 1106
Messeant J, Dobbertin A, Girard E, Delers P, Manuel M, Mangione F, Schmitt A, Le Denmat D, Molgo J, Zytnicki D, Schaeffer L, Legay C, Strochlic L (2015)
MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance
Journal of Neuroscience 35: 4926
Rubio F, Kamp L, Carpino J, Faltin E, Loftin K, Molgo J, Araoz R (2014)
Colorimetric microtiter plate receptor-binding assay for the detection of freshwater and marine neurotoxins targeting the nicotinic acetylcholine receptors
Toxicon 91: 45
Sanchez JA, Otero P, Alfonso A, Ramos V, Vasconcelos V, Araoz R, Molgo J, Vieytes MR, Botana LM (2014)
Detection of Anatoxin-a and Three Analogs in Anabaena spp. Cultures: New Fluorescence Polarization Assay and Toxin Profile by LC-MS/MS
Toxins (Basel) 6: 402
Hess P, Abadie E, Herve F, Berteaux T, Sechet V, Araoz R, Molgo J, Zakarian A, Sibat M, Rundberget T, Miles CO, Amzil Z (2013)
Pinnatoxin G is responsible for atypical toxicity in mussels (Mytilus galloprovincialis) and clams (Venerupis decussata) from Ingril, a French Mediterranean lagoon
Toxicon 75: 16
Corbel V, Stankiewicz M, Pennetier C, Fournier D, Stojan J, Girard E, Dimitrov M, Molgo J, Hougard JM, Lapied B (2012)
Correction: Evidence for inhibition of cholinesterases in insect and mammalian nervous systems by the insect repellent deet
BMC Biol 10: 86
Grandic M, Araoz R, Molgo J, Turk T, Sepcic K, Benoit E, Frangez R (2012)
The non-competitive acetylcholinesterase inhibitor APS12-2 is a potent antagonist of skeletal muscle nicotinic acetylcholine receptors
Toxicol Appl Pharmacol 265: 221
Jackson JJ, Stivala CE, Iorga BI, Molgo J, Zakarian A (2012)
Stability of cyclic imine toxins: interconversion of pinnatoxin amino ketone and pinnatoxin A in aqueous media
J Org Chem 77: 10435
Araoz R, Servent D, Molgo J, Iorga BI, Fruchart-Gaillard C, Benoit E, Gu Z, Stivala C, Zakarian A (2011)
Total synthesis of pinnatoxins A and G and revision of the mode of action of pinnatoxin A
Journal of the American Chemical Society 133: 10499
Araoz R, Molgo J, Tandeau de Marsac N (2010)
Neurotoxic cyanobacterial toxins
Toxicon 56: 813
Bourne Y, Radic Z, Araoz R, Talley TT, Benoit E, Servent D, Taylor P, Molgo J, Marchot P (2010)
Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism
Proc Natl Acad Sci U S A 107: 6076
Quinton L, Girard E, Maiga A, Rekik M, Lluel P, Masuyer G, Larregola M, Marquer C, Ciolek J, Magnin T, Wagner R, Molgo J, Thai R, Fruchart-Gaillard C, Mourier G, Chamot-Rooke J, Menez A, Palea S, Servent D, Gilles N (2010)
Isolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor
British Journal of Pharmacology 159: 316
Rozman KB, Araoz R, Sepcic K, Molgo J, Suput D (2010)
Parazoanthoxanthin A blocks Torpedo nicotinic acetylcholine receptors
Chemico-Biological Interactions 187: 384
Bidon C, Lachuer J, Molgo J, Wierinckx A, De La Porte S, Pignol B, Christen Y, Meloni R, Koenig HL, Biguet NF, Mallet J (2009)
The extract of Ginkgo biloba EGb 761 reactivates a juvenile profile in the skeletal muscle of sarcopenic rats by transcriptional reprogramming
PLoS ONE 4: e7998
Corbel V, Stankiewicz M, Pennetier C, Fournier D, Stojan J, Girard E, Dimitrov M, Molgo J, Hougard JM, Lapied B (2009)
Evidence for inhibition of cholinesterases in insect and mammalian nervous systems by the insect repellent deet
BMC Biol 7: 47
Krieger F, Mourot A, Araoz R, Kotzyba-Hibert F, Molgo J, Bamberg E, Goeldner M (2008)
Fluorescent agonists for the Torpedo nicotinic acetylcholine receptor
Chembiochem 9: 1146
Stum M, Girard E, Bangratz M, Bernard V, Herbin M, Vignaud A, Ferry A, Davoine CS, Echaniz-Laguna A, Rene F, Marcel C, Molgo J, Fontaine B, Krejci E, Nicole S (2008)
Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia
Hum Mol Genet 17: 3166
Vignaud A, Fougerousse F, Mouisel E, Bertrand C, Bonafos B, Molgo J, Ferry A, Chatonnet A (2008)
Genetic ablation of acetylcholinesterase alters muscle function in mice
Chemico-Biological Interactions 175: 129
Girard E, Bernard V, Minic J, Chatonnet A, Krejci E, Molgo J (2007)
Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice
Life Sciences 80: 2380
Barbier J, Lamthanh H, Gall FL, Favreau P, Benoit E, Chen H, Gilles N, Ilan N, Heinemann SH, Gordon D, Menez A, Molgo J (2006)
d-Conopeptide EVIA isolated from Conus ermineus is a new pharmacological tool for discriminating sodium channel subtypes
Journal de Physiologie (Paris) 99: 247
Girard E, Barbier J, Camp S, Taylor P, Chatonnet A, Krejci E, Molgo J (2006)
Synaptic efficacy and remodeling at the neuromuscular junction of knockout mice deficient in acetylcholinesterase
Journal de Physiologie (Paris) 99: 254
Girard E, Bernard V, Camp S, Taylor P, Krejci E, Molgo J (2006)
Remodeling of the neuromuscular junction in mice with deleted exons 5 and 6 of acetylcholinesterase
Journal of Molecular Neuroscience 30: 99
Mouisel E, Blondet B, Escourrou P, Chatonnet A, Molgo J, Ferry A (2006)
Outcome of acetylcholinesterase deficiency for neuromuscular functioning
Neurosci Res 55: 389
Stum M, Girard E, Molgo J, Tabti N, Willer J-C, Fontaine B, Krejci E, Nicole S (2006)
Generation of a mouse model for Schwartz-Jampel syndrome
Journal de Physiologie (Paris) 99: 275
Girard E, Barbier J, Chatonnet A, Krejci E, Molgo J (2005)
Synaptic remodeling at the skeletal neuromuscular junction of acetylcholinesterase knockout mice and its physiological relevance
Chemico-Biological Interactions 157-158: 87
Montecucco C, Molgo J (2005)
Botulinal neurotoxins: revival of an old killer
Curr Opin Pharmacol 5: 274
Nguyen-Huu T, Dobbertin A, Barbier J, Minic J, Krejci E, Duvaldestin P, Molgo J (2005)
Cholinesterases and the resistance of the mouse diaphragm to the effect of tubocurarine
Anesthesiology 103: 788
Minic J, Barbier J, Chatonnet A, Krejci E, Molgo J (2004)
Synaptic transmission at AChE/- and CoIQ-I-knockout mouse neuromuscular junctions
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 19
Minic J, Barbier J, Chatonnet A, Krejci E, Molgo J (2004)
Poster (7) Synaptic transmission at AChE-/- and ColQ knockout mouse neuromuscular junctions
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 324
Minic J, Chatonnet A, Krejci E, Molgo J (2003)
Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions
British Journal of Pharmacology 138: 177
Minic J, Molgo J, Karlsson E, Krejci E (2002)
Regulation of acetylcholine release by muscarinic receptors at the mouse neuromuscular junction depends on the activity of acetylcholinesterase
European Journal of Neuroscience 15: 439
Poh SL, Mourier G, Thai R, Armugam A, Molgo J, Servent D, Jeyaseelan K, Menez A (2002)
A synthetic weak neurotoxin binds with low affinity to Torpedo and chicken alpha7 nicotinic acetylcholine receptors
European Journal of Biochemistry 269: 4247
Feng G, Krejci E, Molgo J, Cunningham JM, Massoulie J, Sanes JR (1999)
Genetic Analysis of Collagen Q: Roles in Acetylcholinesterase and Butyrylcholinesterase Assembly and in Synaptic Structure and Function
Journal of Cell Biology 144: 1349
Cifuentes-Diaz C, Meunier FA, Velasco E, Faille L, Goudou D, Belkadi L, Rieger F, Molgo J, Angaut-Petit D (1998)
Morphological alterations of motor nerve terminals after botulinum type-A poisoning or reinnervation of skeletal muscle in the tenascin-C deficient mouse
Journal de Physiologie (Paris) 92: 421
Favreau P, Legall F, Servent D, Menez A, Molgo J, Letourneux Y (1998)
Two novel alpha-conotoxins isolated from the venom of Conus consor: isolation, synthesis and binding on the Torpedo nicotinic acetylcholine receptor
Journal de Physiologie (Paris) 92: 430
Le Gall F, Favreau P, Benoit E, Letourneux Y, Molgo J (1998)
61 Repetitive and spontaneous acetylcholine release from motor nerve terminals induced by a neurotoxin isolated from Conus ermineus venom
Journal de Physiologie (Paris) 92: 456
Juzans P, Comella JX, Molgo J, Faille L, Angaut-Petit D (1996)
Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle
Neuromuscular Disorders 6: 177
Molgo J, Guglielmi JM (1996)
3,4-Diaminopyridine, an orphan drug, in the symptomatic treatment of Lambert-Eaton myasthenic syndrome
Pflugers Arch 431: R295
Sellin LC, Molgo J, Tornquist K, Hansson B, Thesleff S (1996)
On the possible origin of giant or slow-rising miniature end-plate potentials at the neuromuscular junction
Pflugers Arch 431: 325
Varoqui H, Meunier FM, Meunier FA, Molgo J, Berrard S, Cervini R, Mallet J, Israel M, Diebler MF (1996)
Expression of the vesicular acetylcholine transporter in mammalian cells
Prog Brain Res 109: 83
Poulain B, Molgo J, Thesleff S (1995)
Quantal neurotransmitter release and the clostridial neurotoxins' targets
Curr Top Microbiol Immunol 195: 243
Van der Kloot W, Balezina OP, Molgo J, Naves LA (1994)
The timing of channel opening during miniature endplate currents at the frog and mouse neuromuscular junctions: effects of fasciculin-2, other anti-cholinesterases and vesamicol
Pflugers Arch 428: 114
Kreger AS, Molgo J, Comella JX, Hansson B, Thesleff S (1993)
Effects of stonefish (Synanceia trachynis) venom on murine and frog neuromuscular junctions
Toxicon 31: 307
Pecot-Dechavassine M, Molgo J, Thesleff S (1991)
Ultrastructure of botulinum type-A poisoned frog motor nerve terminals after enhanced quantal transmitter release caused by carbonyl cyanide m-chlorophenylhydrazone
Neuroscience Letters 130: 5
Molgo J, Comella JX, Angaut-Petit D, Pecot-Dechavassine M, Tabti N, Faille L, Mallart A, Thesleff S (1990)
Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions
Journal de Physiologie (Paris) 84: 152
Thesleff S, Molgo J, Tagerud S (1990)
Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins
Journal de Physiologie (Paris) 84: 167
Mallart A, Molgo J, Angaut-Petit D, Thesleff S (1989)
Is the internal calcium regulation altered in type A botulinum toxin-poisoned motor endings?
Brain Research 479: 167
Molgo J, DasGupta BR, Thesleff S (1989)
Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction
Acta Physiologica Scandinavica 137: 497
Molgo J, Pecot-Dechavassine M, Thesleff S (1989)
Effects of cadmium on quantal transmitter release and ultrastructure of frog motor nerve endings
J Neural Transm 77: 79
Molgo J, Siegel LS, Tabti N, Thesleff S (1989)
A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D
Journal of Physiology 411: 195
Molgo J, Angaut-Petit D, Thesleff S (1987)
In botulinum type A-poisoned frog motor endings ouabain induces phasic transmitter release through Na+-Ca2+ exchange
Brain Research 410: 385
Molgo J, Lemeignan M, Thesleff S (1987)
Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin
Muscle & Nerve 10: 464
Lemeignan M, Millart H, Lamiable D, Molgo J, Lechat P (1984)
Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats
Brain Research 304: 166
Molgo J, Thesleff S (1984)
Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction
Brain Research 297: 309
Thesleff S, Molgo J (1983)
A new type of transmitter release at the neuromuscular junction
Neuroscience 9: 1
Thesleff S, Molgo J, Lundh H (1983)
Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction
Brain Research 264: 89
Colmeus C, Gomez S, Molgo J, Thesleff S (1982)
Discrepancies between spontaneous and evoked synaptic potentials at normal, regenerating and botulinum toxin poisoned mammalian neuromuscular junctions
Proc R Soc Lond B Biol Sci 215: 63
Molgo J, Gomez S, Polak RL, Thesleff S (1982)
Giant miniature endplate potentials induced by 4-aminoquinoline
Acta Physiologica Scandinavica 115: 201
Molgo J, Thesleff S (1982)
4-aminoquinoline-induced 'giant' miniature endplate potentials at mammalian neuromuscular junctions
Proc R Soc Lond B Biol Sci 214: 229
Molgo J, Thesleff S (1982)
Electronic properties of motor nerve terminals
Acta Physiologica Scandinavica 114: 271
Molgo J, Lundh H, Thesleff S (1980)
Potency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changes
European Journal of Pharmacology 61: 25